Literature DB >> 6881854

[Pseudopurpuric palmar localizations of herpetiform dermatitis].

G Moulin, D Barrut, M P Franc, P Viornery, S Knezynski.   

Abstract

We report an unusual manifestation of dermatitis herpetiformis in four patients. Three of them fulfill all the criteria for dermatitis herpetiformis: micro-abscesses of polymorphs in the upper papillary dermis, granular IgA deposit on IF examination, gluten-sensitive enteropathy, HLA B8. These peculiar lesions occur on palms and fingers, and appear as a petechial and ecchymotic purpura. A light painful sensation may precede the eruption. In two cases the palmar localisation initiated the course of the disease and remained isolated for more than one year. In only two cases, typical inflammatory lesions were associated on the palms. No lesions occurred on the soles. These peculiar palmar purpura-like lesions cleared with gluten-free diet or Dapsone therapy in the four patients.

Entities:  

Mesh:

Year:  1983        PMID: 6881854

Source DB:  PubMed          Journal:  Ann Dermatol Venereol        ISSN: 0151-9638            Impact factor:   0.777


  4 in total

1.  Dermatitis herpetiformis: relevance of the physical examination to diagnosis suspicion.

Authors:  Paulo Ricardo Criado; Roberta Fachini Jardim Criado; Valeria Aoki; Walter Belda; Ilana Halpern; Gilles Landman; Cidia Vasconcellos
Journal:  Can Fam Physician       Date:  2012-08       Impact factor: 3.275

Review 2.  Newly described clinical and immunopathological feature of dermatitis herpetiformis.

Authors:  Veronica Bonciolini; Diletta Bonciani; Alice Verdelli; Antonietta D'Errico; Emiliano Antiga; Paolo Fabbri; Marzia Caproni
Journal:  Clin Dev Immunol       Date:  2012-06-03

Review 3.  The diagnosis and treatment of dermatitis herpetiformis.

Authors:  Emiliano Antiga; Marzia Caproni
Journal:  Clin Cosmet Investig Dermatol       Date:  2015-05-13

Review 4.  Celiac disease and autoimmune-associated conditions.

Authors:  Eugenia Lauret; Luis Rodrigo
Journal:  Biomed Res Int       Date:  2013-07-24       Impact factor: 3.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.